News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

HK public hospital experience: Earlier use of 2L therapies improves maternal outcomes, despite rise in massive primary PPH
29 Aug 2026
byNatalia Reoutova
A study conducted at a single public maternity unit in Hong Kong reports a 67 percent increase in massive primary postpartum haemorrhage (PPH) between 2006–2011 and 2017–2022, as well as considerable improvements in maternal outcomes, such as lower blood loss and hysterectomy rate, owing to increased use of second-line (2L) therapies.
HK public hospital experience: Earlier use of 2L therapies improves maternal outcomes, despite rise in massive primary PPH
29 Aug 2026
Drug interactions not uncommon in breast cancer patients on chemo
27 Aug 2026
byStephen Padilla
Potential drug-drug interactions (DDIs) exist in breast cancer patients undergoing cyclin-dependent kinase (CDK) 4/6 inhibitors chemotherapy, suggests a study.







